EUROPE SEPSIS DIAGNOSTICS MARKET FORECAST 2021-2028

The Europe sepsis diagnostics market is forecasted to record a CAGR of 8.24%, over the forecast period, 2021-2028. Key aspects, such as, the surging prevalence of sepsis, the increasing mortality rate due to the medical condition, and the need for early disease diagnosis, are expected to fuel the region’s market growth.

europe-sepsis-diagnostics-market

The Europe sepsis diagnostics market growth is evaluated through the assessment of France, Poland, the United Kingdom, Russia, Italy, Belgium, Germany, and the rest of Europe. The United Kingdom’s sepsis diagnostics market is primarily fueled by the increasing number of fatalities caused by sepsis. Numerous studies are also being conducted in the country, in order to minimize the disease burden, by implementing innovative diagnostic techniques and therapeutics. With over 52,000 people killed annually in the country due to sepsis, the medical condition’s death rate is relatively higher across the United Kingdom, than in other European nations. 

On the other hand, the market in France is driven by the surging cases of sepsis, coupled with the rising number of diagnostic firms in the nation. In this regard, according to the Pasteur Institute, a non-profit foundation dedicated to studying vaccines and diseases, the sepsis-related death rate in France is nearly 27%. As a result, these factors are anticipated to propel the sepsis diagnostics market growth in Europe during the forecast years.

F. Hoffmann-La Roche Ltd, headquartered in Switzerland, is a healthcare company that develops and commercializes innovative diagnostic as well as therapeutics products. It researches and manufactures pharmaceutical products across multiple therapeutic avenues, including, immunology, oncology, ophthalmology, neuroscience, and infectious diseases. The company also delivers products related to clinical chemistry, immunoassays, hematology, and hemostasis, among others.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. KEY DRIVERS
      1. PREVAILING BURDEN OF SEPSIS
      2. COMPLICATIONS ARISING DUE TO HOSPITAL-ACQUIRED INFECTIONS (HAIS)
      3. SPREAD OF INFECTIOUS DISEASES AUGMENTING SEPSIS PROCEDURES
      4. SURGING GOVERNMENT INITIATIVES
    2. KEY RESTRAINTS
      1. COMPLICATIONS ASSOCIATED WITH THE REIMBURSEMENT POLICIES
      2. HIGH COST OF AN AUTOMATED DIAGNOSTICS INSTRUMENT
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
    2. KEY INVESTMENT INSIGHTS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY TECHNOLOGY
    1. MICROBIOLOGY
    2. IMMUNOASSAY
    3. MOLECULAR DIAGNOSTICS
    4. OTHER TECHNOLOGIES
  6. MARKET BY DIAGNOSTIC METHOD
    1. CONVENTIONAL DIAGNOSTICS
    2. AUTOMATED DIAGNOSTICS
  7. MARKET BY PRODUCT
    1. BLOOD CULTURE MEDIA
    2. ASSAY KITS & REAGENTS
    3. INSTRUMENTS
  8. MARKET BY PATHOGEN
    1. GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
    2. FUNGAL SEPSIS
    3. OTHER PATHOGENS
  9. MARKET BY TESTING TYPE
    1. LABORATORY TESTING
    2. POINT-OF-CARE TESTING
  10. GEOGRAPHICAL ANALYSIS
    1. EUROPE
      1. MARKET SIZE & ESTIMATES
      2. KEY GROWTH ENABLERS
      3. KEY CHALLENGES
      4. KEY PLAYERS
      5. COUNTRY ANALYSIS
        1. GERMANY
        2. FRANCE
        3. UNITED KINGDOM
        4. ITALY
        5. RUSSIA
        6. BELGIUM
        7. POLAND
        8. REST OF EUROPE
  11. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
      4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
      2. BECTON, DICKINSON AND COMPANY
      3. BIOMERIEUX SA
      4. BRUKER CORPORATION
      5. CYTOSORBENTS
      6. DANAHER
      7. EKF DIAGNOSTICS
      8. F. HOFFMANN-LA ROCHE
      9. IMMUNEXPRESS INC
      10. LUMINEX CORPORATION
      11. RESPONSE BIOMEDICAL CORPORATION
      12. T2 BIOSYSTEMS INC
      13. THERMO FISHER SCIENTIFIC INC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - SEPSIS DIAGNOSTICS

TABLE 2: EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: EUROPE SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: EUROPE SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: EUROPE SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: EUROPE SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: EUROPE SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: EUROPE SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS

TABLE 11: GRAM-POSITIVE BACTERIA CAUSING SEPSIS

TABLE 12: EUROPE SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: EUROPE SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: EUROPE SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: EUROPE SEPSIS DIAGNOSTICS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: LEADING PLAYERS OPERATING IN EUROPE SEPSIS DIAGNOSTICS MARKET

TABLE 17: LIST OF MERGERS & ACQUISITIONS

TABLE 18: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

TABLE 19: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 20: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE SEPSIS DIAGNOSTICS MARKET, BY TECHNOLOGY, IN 2020

FIGURE 6: EUROPE SEPSIS DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)

FIGURE 7: EUROPE SEPSIS DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)

FIGURE 8: EUROPE SEPSIS DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 9: EUROPE SEPSIS DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 10: EUROPE SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, IN 2020

FIGURE 11: EUROPE SEPSIS DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 12: EUROPE SEPSIS DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 13: EUROPE SEPSIS DIAGNOSTICS MARKET, BY PRODUCT, IN 2020

FIGURE 14: EUROPE SEPSIS DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)

FIGURE 15: EUROPE SEPSIS DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)

FIGURE 16: EUROPE SEPSIS DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

FIGURE 17: EUROPE SEPSIS DIAGNOSTICS MARKET, BY PATHOGEN, IN 2020

FIGURE 18: EUROPE SEPSIS DIAGNOSTICS MARKET, BY GRAM - POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 19: EUROPE SEPSIS DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)

FIGURE 20: EUROPE SEPSIS DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)

FIGURE 21: EUROPE SEPSIS DIAGNOSTICS MARKET, BY TESTING TYPE, IN 2020

FIGURE 22: EUROPE SEPSIS DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)

FIGURE 23: EUROPE SEPSIS DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)

FIGURE 24: EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 25: GERMANY SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 26: FRANCE SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 27: UNITED KINGDOM SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 28: ITALY SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 29: RUSSIA SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 30: BELGIUM SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 31: POLAND SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

FIGURE 32: REST OF EUROPE SEPSIS DIAGNOSTICS MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample